No Data
No Data
No Data
No Data
No Data
Express News | NYSE Order Imbalance 158865.0 Shares on Sell Side
Moomoo 24/7Apr 24 15:50 ET
Goldman's Debt Issuers Stocks Basket
Seeking AlphaApr 22 12:53 ET
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
BMO Capital Markets initiated coverage on Danish drug maker Novo Nordisk A/S (NYSE:NVO) after the company garnered interest as it hit the holy grail with the next generation of famed weight loss and d
BenzingaApr 12 13:22 ET
Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target Is $48
Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48.
MT NewswiresApr 12 10:36 ET
Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)
TipRanksApr 12 01:41 ET
Express News | NYSE Order Imbalance 78033.0 Shares on Buy Side
Moomoo 24/7Apr 11 15:50 ET
No Data
No Data